1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue
1.4 Market Analysis by Type
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Live Vaccine
1.4.3 Inactivated Vaccine
1.5 Market by Application
1.5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application: 2021-2026
1.5.2 Government Tender
1.5.3 Marketing
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market
1.8.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Market Share by Region (2015-2020)
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume
3.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume
3.4.1 East Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.5.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.6.1 South Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.7.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.8.1 Middle East Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.9.1 Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.10.1 Oceania Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.11.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume (2015-2020)
3.12.1 Rest of the World Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Volume Market Share by Type (2015-2020)
14.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption Volume by Application (2015-2020)
15.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Business
16.1 CNADC
16.1.1 CNADC Company Profile
16.1.2 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Qilu Animal Health
16.2.1 Qilu Animal Health Company Profile
16.2.2 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.2.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Sinopharm
16.3.1 Sinopharm Company Profile
16.3.2 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.3.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Boehringer-Ingelheim
16.4.1 Boehringer-Ingelheim Company Profile
16.4.2 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.4.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Tianjin Ruipu Biological Technology Co., Ltd.
16.5.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Profile
16.5.2 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.5.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 MSD Animal Health
16.6.1 MSD Animal Health Company Profile
16.6.2 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.6.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 CAVAC
16.7.1 CAVAC Company Profile
16.7.2 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.7.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Chengdu Tianbang Biological Products Co., Ltd.
16.8.1 Chengdu Tianbang Biological Products Co., Ltd. Company Profile
16.8.2 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.8.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Ceva
16.9.1 Ceva Company Profile
16.9.2 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.9.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
16.10.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Profile
16.10.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.10.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Phibro Animal Health
16.11.1 Phibro Animal Health Company Profile
16.11.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.11.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Guangdong Yongshun Biological Pharmaceutical Co Ltd
16.12.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Profile
16.12.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.12.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Komipharm
16.13.1 Komipharm Company Profile
16.13.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.13.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Tiankang
16.14.1 Tiankang Company Profile
16.14.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.14.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Jinyu Bio-Technology
16.15.1 Jinyu Bio-Technology Company Profile
16.15.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.15.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Agrovet
16.16.1 Agrovet Company Profile
16.16.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.16.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Plec Bioengineering Co., Ltd.
16.17.1 Plec Bioengineering Co., Ltd. Company Profile
16.17.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.17.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Zoetis
16.18.1 Zoetis Company Profile
16.18.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.18.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Bioveta
16.19.1 Bioveta Company Profile
16.19.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Specification
16.19.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis
17.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
17.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
18.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) (2021-2026)
20.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) (2021-2026)
20.3 Global Forecasted Price of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) (2015-2026)
20.4 Global Forecasted Production of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2021-2026)
20.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.9 South America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.2 East Asia Market Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.3 Europe Market Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Countriy
21.4 South Asia Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.5 Southeast Asia Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.6 Middle East Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.7 Africa Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.8 Oceania Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.9 South America Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
21.10 Rest of the world Forecasted Consumption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer